Tirzepatide

Buy Tirzepatide

Tirzepatide is an investigational once-weekly dual GIP and GLP-1 receptor agonist that is being developed for the treatment of type 2 diabetes. It is a peptide that mimics the action of two natural hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), which are involved in regulating blood sugar levels and digestion. By activating these receptors, tirzepatide enhances the body's own ability to produce insulin, reduces glucagon secretion, slows gastric emptying, and decreases appetite, potentially leading to improved glucose control and weight management in people with type 2 diabetes. It is currently under clinical study and not yet approved for use.